TScan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.About TCRX
TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts.
TCRX Key Statistics
Stock Snapshot
As of today, TScan Therapeutics(TCRX) shares are valued at $0.92. The company's market cap stands at 60.18M, with a P/E ratio of -0.96.
On 2026-06-20, TScan Therapeutics(TCRX) stock moved within a range of $0.87 to $0.93. With shares now at $0.92, the stock is trading +5.5% above its intraday low and -1.4% below the session's peak.
Trading activity shows a volume of 406.29K, compared to an average daily volume of 436.71K.
The stock's 52-week range extends from a low of $0.85 to a high of $2.57.
The stock's 52-week range extends from a low of $0.85 to a high of $2.57.
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.